Zika Virus

Zika virus is a member of the virus family Flaviviridae and the genus Flavivirus, transmitted by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus
What is the Zika virus?

The Zika virus causes fever, joint pain, headaches, a rash, conjunctivitis and muscle pain. As with other viruses, it is characterised by spreading via the cells of the body. Both men and women can contract the disease. It is a member of the Flavivirus genus which is a member of the Flaviviridae family.

Read More

Overview

Feature Articles

Latest Zika Virus News and Research

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

Resveratrol shows potential as SARS-CoV-2 antiviral, study finds

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

SARS-CoV-2 versus Zika: Comparing and contrasting the flow of research

Widely used antibiotic shows promise for fighting against Zika infections

Widely used antibiotic shows promise for fighting against Zika infections

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Study may help develop effective drugs against COVID-19

Study may help develop effective drugs against COVID-19

Genomic surveillance of yellow fever outbreak in São Paulo

Genomic surveillance of yellow fever outbreak in São Paulo

Study shows T cells can prevent Zika infection in mice

Study shows T cells can prevent Zika infection in mice

Eye's cornea can resist infection from novel coronavirus

Eye's cornea can resist infection from novel coronavirus

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

First-of-its-kind synthetic DNA vaccine designed against Powassan virus

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Researchers describe factors that reduce placenta's capacity to protect fetus from zika virus

Researchers describe factors that reduce placenta's capacity to protect fetus from zika virus

Research elucidates the molecular mechanism of lentiviral cross-species transmission

Research elucidates the molecular mechanism of lentiviral cross-species transmission

Study shows how Zika virus degrades key protein involved in neurological growth

Study shows how Zika virus degrades key protein involved in neurological growth

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Study shows what happens in the fetal brain affected by congenital Zika syndrome

Study shows what happens in the fetal brain affected by congenital Zika syndrome

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

DNA nanoswitches may provide an inexpensive platform to rapidly detect emerging viruses

DNA nanoswitches may provide an inexpensive platform to rapidly detect emerging viruses